About
SERB Specialty Pharmaceuticals is a European specialty pharmaceutical group that develops, acquires and markets prescription medicines for rare and life‑threatening diseases. It commercializes a portfolio of niche specialty drugs through direct operations in Europe, the Middle East and Australia and via a distributor network in over 80 countries.
Explore SERB Specialty Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.